期刊文献+

氯丙米嗪合并氯丙嗪治疗强迫症疗效分析

The effectiveness analysis of obsessive-compulsive disorder (OCD) treated by chlorpromazine and clomipramine
暂未订购
导出
摘要 目的:探讨氯丙米嗪合并氯丙嗪治疗强迫症的临床疗效。方法:对原用氯丙米嗪治疗为主的52例强迫症患者随机分成两组,一组加用氯丙嗪(研究组),另一组仍用氯丙米嗪(对照组),治疗8周,用Y-BOCS、HAMA评定两组精神症状变化,用t检验对照分析。结果:研究组的HAMA、Y-BOCS总分比对照组明显下降,且有显著性差异(P<0.01)。结论:强迫症患者,采用氯丙嗪合并氯丙米嗪治疗,可提高疗效。 Objective :To observe the clinical efficacy of chlorpromazine and clomipramine in the treatment of obsessive - compulsive disorder (OCD). Methods :52 cases of obsessive -compulsive disorder patients, who were cured by clomipramine in the previous treatment, were divided randomly into two groups. One of them, which was called as the treatment group, were cured combined with chlorpromazine for the next 8 weeks, while the other one (the control group) were still going on treated by clomipramine only during the period. Over the duration of treatment, Y - BOCS and HAMA were used to evaluate the changes of mental symptoms of patients of these two groups. At the same time, t - test was also used to analyse them. Results: The total score of Y - BOCS and HAMA of the treatment group was decreased sharply compared with that of the control group and the differences between these two groups are significant (P 〈 0.01 ). Conclusions: The curative effect of obsessive - compulsive disorder (OCD) will be improved by using chlorpromazinc combined with clomipramine.
作者 雷雨 刘伟
出处 《中国民康医学》 2011年第5期558-559,共2页 Medical Journal of Chinese People’s Health
关键词 氯丙嗪 强迫症 氯丙米嗪 Chlorpromazine Obsessive - compulsive disorder Clomipramine
  • 相关文献

参考文献3

二级参考文献21

  • 1Thoren P, Abserg M, Cronholm B, et al. Clomipramine treatment of obsessive compulsive disorder. L A controlled clinical trial. Arch Gen Psychiatry, 1980, 37: 1281
  • 2Zohar J, Insel TR. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol Psychiatry, 1987, 22 : 667
  • 3Goodman WK, Price LH, Delgado PL, et al. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine. Arch Gen Psychiatry, 1990, 47 : 577
  • 4Tollefson GD, Rampey AH, Potvin JH, et al. A multicenter invesigation of fixed-dose fluoxetine in the treatment of obsessivecompulsive disorder. Arch Gen Psychiatry, 1994, 51 : 559
  • 5Montogomery SA, McIntyre A, Osterheider M, et al. A doubleblind, placebo-controlled study of fluoxetine in patients with DSMⅢ-R obsessive-compulsive disorder. Eurneuropsychopharmalcol,1993, 3 : 143
  • 6Chouinard G, Goodman W, Greist J, et al. Results of a doubleblind, placebo-controlled trial of a new serotonin reuptake inhibitor, sretraline, in the treatment of obsessive-compulsive disorder. Psychopharmalcol Bull, 1990, 26: 279
  • 7Fgelson DL, Bystritsky A. Imipramine in the treatment of obsessive-compulsive disorder with and without major depression. Ann Clin Psychiatry, 1991, 3: 233
  • 8Hewlett WA, Vinogradov S, Agras WS. Clomipramine, clonazepam and clondine treatment of obsessive-compulsive disorder. J Clin Psychopharmalcol, 1992, 12 : 420
  • 9Vallejo J, Olivares J, Marcos T, et al. Clomipramine versus phenelzine in obsessive-compulsive disorder: a controlled clinical trial. Br J Psychiatry, 1992, 161: 665
  • 10Jenike MA, Hyman S, Baer L, et al. A controlled clinical trial of fluvoxamine in obsessive-compulsive disorder: Implications for a serotonergic theory. Am J Psychiatry, 1990, 147: 1209

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部